Potent neutralization by monoclonal human IgM against SARS‐CoV‐2 is impaired by class switch-Reference-Cited by-同舟云学术

Potent neutralization by monoclonal human IgM against SARS‐CoV‐2 is impaired by class switch

Published:2022-05-12 Issue:7 Volume:23 Page:
ISSN:1469-221X
Container-title:EMBO reports
language:en
Short-container-title:EMBO Reports

Author:

Callegari Ilaria¹²^ORCID,Schneider Mika¹,Berloffa Giuliano¹^ORCID,Mühlethaler Tobias³,Holdermann Sebastian¹²^ORCID,Galli Edoardo¹²^ORCID,Roloff Tim⁴⁵,Boss Renate⁶,Infanti Laura⁷,Khanna Nina⁸,Egli Adrian⁴⁵^ORCID,Buser Andreas⁷^ORCID,Zimmer Gert⁹¹⁰^ORCID,Derfuss Tobias¹²,Sanderson Nicholas S R¹²^ORCID

Affiliation:

1. Department of Biomedicine University of Basel and University Hospital Basel Basel Switzerland

2. MS Center, Neurologic Clinic and Policlinic, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) University Hospital Basel University of Basel Basel Switzerland

3. Biophysics Facility Biozentrum University of Basel Basel Switzerland

4. Applied Microbiology Research Department of Biomedicine University of Basel Basel Switzerland

5. Clinical Bacteriology and Mycology University Hospital Basel Basel Switzerland

6. Federal Food Safety and Veterinary Office Bern Switzerland

7. Regional Blood Transfusion Service, Swiss Red Cross Basel Switzerland

8. Infectious Diseases and Hospital Epidemiology University Hospital Basel Basel Switzerland

9. Institute of Virology and Immunology Bern & Mittelhäusern Switzerland

10. Department of Infectious Diseases and Pathobiology Vetsuisse Faculty University of Bern Bern Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

EMBO

Subject

Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/embr.202153956

Reference49 articles.

1. B cells acquire antigen from target cells after synapse formation

2. Affinity Dependence of the B Cell Response to Antigen: A Threshold, a Ceiling, and the Importance of Off-Rate

3. Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine

4. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

5. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies;Viruses;2024-04-28

2. Defining and Studying B Cell Receptor and TCR Interactions;The Journal of Immunology;2023-08-01

3. Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues;Frontiers in Immunology;2023-06-08

4. Status and Developing Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19;Viruses;2023-05-31

5. Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein;2023-04-11